Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance
- PMID: 39843522
- PMCID: PMC11754592
- DOI: 10.1038/s41467-025-56309-8
Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance
Abstract
Microbial species must compete for space and nutrients to persist in the gastrointestinal (GI) tract, and our understanding of the complex pathobiont-microbiota interactions is far from complete. Klebsiella pneumoniae, a problematic, often drug-resistant nosocomial pathogen, can colonize the GI tract asymptomatically, serving as an infection reservoir. To provide insight on how K. pneumoniae interacts with the resident gut microbiome, we conduct a transposon mutagenesis screen using a murine model of GI colonization with an intact microbiota. Among the genes identified were those encoding a type VI secretion system (T6SS), which mediates contact-dependent killing of gram-negative bacteria. From several approaches, we demonstrate that the T6SS is critical for K. pneumoniae gut colonization. Metagenomics and in vitro killing assays reveal that K. pneumoniae reduces Betaproteobacteria species in a T6SS-dependent manner, thus identifying specific species targeted by K. pneumoniae. We further show that T6SS gene expression is controlled by several transcriptional regulators and that expression only occurs in vitro under conditions that mimic the gut environment. By enabling K. pneumoniae to thrive in the gut, the T6SS indirectly contributes to the pathogenic potential of this organism. These observations advance our molecular understanding of how K. pneumoniae successfully colonizes the GI tract.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures







Similar articles
-
Klebsiella pneumoniae type VI secretion system-mediated microbial competition is PhoPQ controlled and reactive oxygen species dependent.PLoS Pathog. 2020 Mar 19;16(3):e1007969. doi: 10.1371/journal.ppat.1007969. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32191774 Free PMC article.
-
Klebsiella pneumoniae Type VI Secretion System Contributes to Bacterial Competition, Cell Invasion, Type-1 Fimbriae Expression, and In Vivo Colonization.J Infect Dis. 2019 Jan 29;219(4):637-647. doi: 10.1093/infdis/jiy534. J Infect Dis. 2019. PMID: 30202982 Free PMC article.
-
A combination of genomics and transcriptomics provides insights into the distribution and differential mRNA expression of type VI secretion system in clinical Klebsiella pneumoniae.mSphere. 2024 Mar 26;9(3):e0082223. doi: 10.1128/msphere.00822-23. Epub 2024 Mar 4. mSphere. 2024. PMID: 38436228 Free PMC article.
-
Type VI Secretion Systems and the Gut Microbiota.Microbiol Spectr. 2019 Mar;7(2):10.1128/microbiolspec.psib-0009-2018. doi: 10.1128/microbiolspec.PSIB-0009-2018. Microbiol Spectr. 2019. PMID: 30825301 Free PMC article. Review.
-
Deciphering the gastrointestinal carriage of Klebsiella pneumoniae.Infect Immun. 2024 Sep 10;92(9):e0048223. doi: 10.1128/iai.00482-23. Epub 2024 Apr 10. Infect Immun. 2024. PMID: 38597634 Free PMC article. Review.
Cited by
-
Arginine regulates the mucoid phenotype of hypervirulent Klebsiella pneumoniae.Nat Commun. 2025 Jul 1;16(1):5875. doi: 10.1038/s41467-025-61047-y. Nat Commun. 2025. PMID: 40595687 Free PMC article.
-
Arginine at the host-pathogen interface.Infect Immun. 2025 Aug 12;93(8):e0061224. doi: 10.1128/iai.00612-24. Epub 2025 Jul 3. Infect Immun. 2025. PMID: 40607975 Free PMC article. Review.
-
The Negative Regulatory Role of Transcriptional Regulator H-NS on the Type VI Secretion System in Acinetobacter baumannii.Infect Drug Resist. 2025 Jun 12;18:2997-3011. doi: 10.2147/IDR.S512650. eCollection 2025. Infect Drug Resist. 2025. PMID: 40529232 Free PMC article.
-
Murine Models of Klebsiella pneumoniae Gastrointestinal Infection.Curr Protoc. 2025 Aug;5(8):e70187. doi: 10.1002/cpz1.70187. Curr Protoc. 2025. PMID: 40762426 Free PMC article.
-
The mechanisms of antibiotic resistance and drug resistance transmission of Klebsiella pneumoniae.J Antibiot (Tokyo). 2025 Aug 27. doi: 10.1038/s41429-025-00860-5. Online ahead of print. J Antibiot (Tokyo). 2025. PMID: 40866567 Review.
References
MeSH terms
Substances
Grants and funding
- AI166642/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R21 AI166642/AI/NIAID NIH HHS/United States
- T32 AI007151/AI/NIAID NIH HHS/United States
- T32 AI007401/AI/NIAID NIH HHS/United States
- AI178595/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
LinkOut - more resources
Full Text Sources
Molecular Biology Databases